Introduction
Photothermal therapy (PTT) has received extensive interests as a promising non-invasive methodology to targetedly "burn" cancer cells with the aid of photoabsorbers in combination with near infrared (NIR) laser irradiation [1] [2] [3] [4] . Until now, numerous of nanomaterials, such as Au- [5] [6] [7] [8] [9] , copper sulfide- [10] [11] [12] [13] [14] [15] , and carbon- [16] [17] [18] nanostructures have been explored as potential photoabsorbers to ablate cancer cells due to their strong NIR absorption and excellent photothermal conversion property. In addition, a variety of theranostic agents have been developed by integrating the functions of medical imaging with PTT to identify the location and size of tumors before the therapy, and monitor the therapeutic procedure in real-time [19] [20] [21] [22] [23] [24] .
Prussian blue (PB) has been approved for treatment of radioactive exposure in clinic [25] . Owning to the excellent absorption in the NIR wavelength region, a number of PB based theranostic agents have been explored for imaging guided PTT of cancer [26] [27] [28] [29] [30] [31] . Magnetic iron oxide nanoparticles (Fe3O4 NPs) have emerged as a versatile agent for magnetic resonance (MR) imaging and magnetic targeting of tumors due to their efficacy and safety [32] [33] [34] [35] [36] . In our previous report, magnetic Prussian blue (Fe 3 O 4 @PB) NPs were prepared by in situ growing PB shells on the surface of Fe 3 O 4 NPs for MR imaging guided PTT of tumor [37] . Nevertheless,
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International Publisher MR imaging has relatively long scanning time and low sensitivity in spite of high spatial resolution [38] [39] [40] . In recent years, NIR fluorescence cancer imaging is a growing field for both preclinical and clinical application to cancer patients because of high sensitivity and specificity, operational simplicity, real-time display, safety and cost effectiveness. As a result, the combination of NIR fluorescence and MR imaging shows great promise in enhancement of precisely diagnosis [41] [42] [43] [44] . Therefore, we have pressing need for the development of nanoparticles for targeting cancer PTT combining fluorescence and magnetic resonance imaging.
Due to high NIR photoluminescence, deeper tissue penetration, and good biocompatibility, the cadmium-free CuInS2-ZnS (ZCIS) quantum dots (QDs) have been fabricated for in vivo imaging applications [45] [46] [47] . In this paper, hyaluronic acid (HA) conjugated magnetic Prussian blue@QD NPs were fabricated for targeted PTT under the guidance of NIR fluorescence/MR bimodal imaging. Fe3O4@PB (FP) NPs were prepared via in situ growth of PB shell on Fe 3 O 4 core [37] , followed by coating with polyethyleneimine (PEI). Then, both bovine serum albumin (BSA) coated ZCIS QDs (BQDs) and HA were conjugated to Fe 3 O 4 @PB@PEI (FPP) NPs via the coupling reaction between the amino of PEI and the carboxyl of both BQDs and HA to obtain Fe 3 O 4 @PB@PEI@BQDs-HA (FPPBH) NPs (Figure 1) . In FPPBH NPs, each component has different function. Hyaluronic acid, a major constituent of extracellular matrix, has good biocompatibility [48] [49] , and capability to specifically bind CD44 receptor overexpressed in various cancer cells through receptor-ligand interaction [50] [51] [52] , rendering the HA modified NPs attractable for cancer targeted imaging and therapy. The Fe3O4 core has the dual functions of magnetic targeting and MR imaging, while its external PB shell acts as an NIR photoabsorber for PTT. ZCIS QDs serves as an NIR fluorescent imaging agent. We characterized the physicochemical properties of the nanoagent including morphology, size distribution, photothermal capability. The in vitro experiments demonstrated the specificity of the obtained FPPBH NPs to tumor cells. In vivo tumor targeting of the FPPBH NPs was visualized in a mouse model by using fluorescence and MR imaging. Quantitative analysis was performed to evaluate the efficacy of MRI contrast enhancement. The photothermal cytotoxicity of the FPPBH NPs was evaluated using both cancer cells and tumor-bearing nude mice. Synthesis of ZCIS QDs: ZCIS QDs were prepared using the modified method according to our previous report [53] . Briefly, 8 mmol zinc acetate was completely dissolved in 6mL of decylamine and 14.0 mL of octadecene, followed by stirring at 160 °C under nitrogen flow for 10 min. The obtained Zn precursor solution was stored at 50 °C for use. Then, 0.1 mmol copper iodide, 0.1 mmol indium acetate, 1 mL of 1-dodecanethiol, 8 mL of octadecene and 0.3 mmol stearic acid were added into a 50 mL three-necked flask under vigorous magnetic stirring under the protection of nitrogen. When the solution was clear, the temperature was raised to 120 °C. After 30 min, the reaction mixture was heated to 230 °C and allowed for 20 min. Then, 1.25 mL Zn precursor was injected into the reaction mixture in 5 batches with a time interval of 15 min. Another 15 min later, the reaction mixture was naturally cooled to room temperature, and equal volume of chloroform was added thereafter. The obtained ZCIS QDs were precipitated by adding methanol and purified by repeated centrifugation and decantation. Zinc concentration was determined by Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) and set as the concentration of ZCIS QDs.
Materials and methods

Materials
Modification of ZCIS QDs with BSA: 1.2 μmol ZCIS QDs in chloroform were added into 50 mL of BSA aqueous solution (200 mg/mL), followed by probe sonication for 5 min. The mixture was stirred vigorously for 2 hours to remove remaining chloroform. Then, the obtained BQDs NPs were washed with deionized water using a Millipore ultrafiltration centrifuge tube (100 kDa cutoff size) for 30 min centrifugation at 5 000 rpm. 31k NPs for 15 min, followed by 4h incubation without external magnetic field. Then, the cells were rinsed with fresh PBS for 3 times, and the nuclei were strained with 4',6-diamidino-2-phenylindole (DAPI) for microscopic observation on a confocal laster scanning microscopy (CLSM, Carl Zeiss 510, Germany) at excition of 430 nm.
HeLa cells and U87MG cells were seeded in 24-well plates at a density of 1×10 5 cells per well. After 24 h incubation at 37 °C with 5 vol.% CO 2 , the cell medium was replaced by fresh medium contain FPPB NPs, FPPBH 6k NPs or FPPBH 31k NPs at the same iron concentration of 10 mg/L. After various treatments, the cells were rinsed with PBS for 3 times, centrifuged at 500 × g for 10 min after trypsinization, re-suspended in PBS, and measured by flow cytometer (FCM, BD FACSCalibur, USA). In vitro and in vivo MR imaging: In vitro and in vivo MR imaging were performed with a 3.0 T whole-body magnetic resonance imaging scanner (Philips Medical Systems). For in vitro MR imaging, the relaxivity value (r2, mM -1 ·s -1 ) was calculated from the slopes of relaxation time (T 2 ) versus the concentration of iron, and T 2 -weighted images of FPPBH 31k NPs at different iron concentration in PBS were obtained using the following parameters: repetition time (TR) = 3000 ms, echo time (TE) = 80 ms, slice thickness of 1.3 mm.
For in vitro MR imaging of cells, HeLa cells and U87MG cells were seeded in 24-well plates at a density of 1×10 5 cells per well. After 24 h incubation at 37 °C with 5 vol.% CO 2 , the cell medium was replaced by fresh medium containing FPPB NPs, FPPBH 6k NPs or FPPBH 31k NPs at the same iron concentration of 10 mg/L. After various treatments, the cells were rinsed with PBS for 3 times, centrifuged at 500 × g for 10 min after trypsinization, re-suspended in PBS, and measured.
For in vivo MR imaging, tumor-bearing BALB/c nude mice were intraveneously (i.v.) injected with 100 μL of FPPB NPs (1.6×10 3 mg/L) or FPPBH 31k NPs (4.0×10 3 mg/L) at the iron concentration of 900 mg/L (n=6 for each group), respectively. For the magnetically targeted group, a permanent magnet was pasted to tumor by a piece of scotch tape for 15 min before imaging. T 2 -weighted images were obtained before and at the time points of 8 h and 24 h after injection.
Temperature elevation induced by NIR laser irradiation: FPPBH 31k NPs with different iron concentration dispersed in RPMI-1640 medium were poured in quartz cuvettes (total volume of 3.0 mL), and irradiated by a continuous-wave diode NIR laser (T808D2W, Xi'an Minghui Optoelectronic Technology Co., China) with a center wavelength of 808 ± 10 nm at output power of 2 W for 10 min. The temperature of all samples was measured by a digital thermometer with a thermocouple probe every 10 s. RPMI-1640 medium was irradiated by NIR laser as control.
The photothermal stability of FPPBH31k NPs was also investigated. FPPBH 31k NPs suspensions with iron concentration of 80 mg/L were irradiated with NIR laser for 10 min, followed by turn off the laser to cooling the sample to room temperature. This cycle repeated for 4 times, and the UV-vis absorption and fluorescence spectra of the irradiated FPPBH31k NPs suspensions were measured to evaluate the stability.
In vitro targeted photothermal ablation effect of FPPBH 31k NPs: HeLa cells were seeded in 6-well plates at a density of 2×10 5 cells per well and incubated at 37 °C with 5 vol.% CO 2 for 24h. Then, the cell medium was replaced by 1 mL FPPBH 31k NPs or FPPB NPs suspension with the iron concentration of 40 mg/L. After 2h incubation, the culture medium with FPPBH 31k NPs or FPPB NPs was removed and 1 mL fresh RPMI-1640 medium was added into each well. Afterwards, the cells were exposed to NIR laser (808 nm, 2 W/cm 2 , diameter of laser spot: 2mm) for 10 min. For the magnetically targeted photothermal group, a permanent magnet was placed under the cell-growing plate bottom for 15 min before the irradiation. After incubated for another 2 h, the cells were rinsed with PBS and stained with calcein acetoxymethyl ester (calcein AM) to verify the targeted photothermal effect of FPPBH31k NPs on cancer cells.
MTT assay was used to evaluate the targeted photothermal effect of FPPBH 31k NPs in vitro. HeLa cells were seeded in 96-well plates at a density of 1×10 4 cells per well and incubated at 37 °C with 5 vol.% CO 2 for 24h. The cell medium was replaced by different iron concentrations of FPPBH 31k NPs or FPPB NPs suspension (200 μL per well) and incubated at 37 °C for 4h. Then, the cells were rinsed with PBS for 3 times, 200 μL of fresh RPMI-1640 medium was added into each well. Afterwards, the cells were exposed to NIR laser (808 nm, 2 W/cm 2 , diameter of laser spot: 2mm) for 10 min. For the magnetically targeted photothermal group, a magnet was placed under the plate bottom for 15 min before the irradiation. After the irradiation, the cells were incubated with fresh RPMI-1640 medium at 37 °C for 24 h. Finally, the cell viabilities were measured by standard MTT method, the optical density of untreated cells was set as 100%.
In vivo PTT efficacy evaluation: Tumor-bearing nude mice were randomly divided in to seven groups (n = 8). Three groups tumor-bearing nude mice were i.v. injected 100 μL of saline, FPPB NPs (1.6×10 3 mg/L) or FPPBH 31k NPs (4.0×10 3 mg/L) at the same iron concentration, respectively. After 24h, the tumor of each mouse was irradiated by a continuous-wave diode NIR laser at 2 W/cm 2 for 10 min. For the magnetically targeted group, 100 μL of FPPBH 31k NPs (4 mg/mL) were i.v. injected into tumor-bearing nude mice, and a permanent magnet was pasted to tumor by a piece of scotch tape for 15 min before irradiation. The body surface temperature of mice were recorded by an infrared (IR) thermal camera during the irradiation every 2 min. The other three groups, tumor-bearing nude mice were i.v. injected saline, FPPB NPs or FPPBH31k NPs without NIR laser irradiation were used as the controls. The tumor volume of nude mice were measured every 3 days post irradiation to evaluate PTT efficacy.
Biocompatibility evaluation: Human umbilical vein endothelial (HUVEC) cells were seeded in 96-well plate at a density of 5×10 4 cells per well for 24 h. The cells were rinsed three times with PBS, followed by incubation with 200 μL different iron concentration of FPPBH 31k NPs in RPMI-1640 medium at 37 °C and 5 vol.% CO 2 for 28 h, 48h and 72h. Cell viabilities were measured by standard MTT method.
The in vivo biocompatibility of FPPBH 31k NPs in mice was also investigated by histological analysis. Healthy BALB/c mice were i.v. injected double imaging/therapy dose of FPPBH 31k NPs (100 μL, 8×10 3 mg/L) (n=6), major organs (heart, liver, spleen, lung and kidneys) were excised at day 1 and day 30 postinjection. Then, the organs were fixed with 10% neutral buffered formalin, made into paraffin embedded sections, stained with hematoxylin and eosin (H&E), and calculated under a digital microscope (Olympus IX, Japan). Healthy mice without FPPBH31k NPs injection were set as control. The body weight of mice were also monitored every 2 day. The tumor growth inhibition (TGI) was monitored post-injection and calculated as the TGI (%) = (1 -T e / T c ) × 100%, where T e = mean tumor volume of experimental groups at day 18, and T c = mean tumor volume of untreat control groups at day 18.
Statistical analysis. Analysis of variance (ANOVA) and t-tests were performed to analyze the statistical significance of the experiment data. The level of significance in statistical analyses was defined as p< 0.05.
Results and Discussion
Preparation and characterization of FPPBH NPs
Highly photoluminescent ZCIS QDs were synthesized in 1-octadecene by using acetate salts of Cu, In, and Zn as cation precursor and dodecanethiol as the sulfur source according to the reported method [53] . Afterwards, BSA, which owns one free sulfhydryl and eight pairs of disulfide bounds inside the macromolecule, was used as surface capping agent to make hydrophobic QDs water soluble [54] . The potential toxicity of heavy metal elements has always limited the clinical application of QDs. It has been reported that BSA could be used to decrease the potential toxicity of QDs by alleviating the release of metal elements [55] . In this study, cadmium-free ZCIS QDs were modified with BSA to increase the biocompatibility of QDs. The obtained BQDs had a hydrodynamic diameter of 14.2 nm (particles distribution index, PDI = 0.149±0.09) (Figure S1A) . BQDs displayed bright red fluorescence under a UV lamp (inset of Figure S1A ). The TEM characterization clearly indicated that BQDs NPs were uniform and well dispersed ( Figure S1B ). As seen in Figure S1C and S1D, BQDs NPs had a strong adsorption in the ultraviolet region like ZCIS QDs, while the fluorescence intensity decreased slightly, accompanied by a visible red shift of the two fluorescence emission peak from 650 and 700 nm to 670 and 720 nm, respectively. It revealed that more defects on the ZCIS QDs surfaces were formed when native ligands were replaced with BSA, leading to a slight fluorescence intensity decrease [56] .
The core-shell Fe3O4@PB NPs were prepared by in situ growing PB shells on superparamagnetic Figure S2) . The zeta potential of FP NPs was -9.73±2.26 mV comparing to -7.95±3.11 mV of Fe3O4 NPs (Figure S3) . Moreover, the UV-vis spectra of FP NPs exhibited a strong typical adsorption peak of PB NPs at NIR region (~700 nm) (Figure 2A) , indicating that PB was successfully deposited on the Figure S4 , the zeta potential of FPPB NPs decreased with reducing mass ratio of FPP/BQDs. The zeta potential was reduced to -6.07±4.58 mV at mass ratio of 2:1, indicating the free amino groups of FPP NPs were occupied by BQDs NPs. The FPPB NPs obtained at the mass ratio of 10:1 was selected to ensure sufficient amino groups for further conjugation of hyaluronic acid. At the FPP/BQDs mass ratio of 10:1, the hydrodynamic diameter of FPPB NPs was 121.0±7.4 nm (PDI = 0.296±0.014), and the zeta potential was +14.36±3.44 mV. Furthermore, as shown in Figure 2F , it could be observed that BQDs were conjugated onto the surface of FPP NPs.
The successful formation of FPPB NPs was also confirmed by observing typical fluorescence emission peaks of BQDs NPs in FPPB NPs aqueous solution ( Figure 2B ). The fluorescence of QDs can be quenched by fluorescence resonance energy transfer (FRET) when the emission spectrum of QDs overlaps with the absorption spectrum of another material at the distances less than 10 nm [57] . It has been reported to protect the fluorescence of QDs from being quenched by coating QDs with macromolecules or inorganic nonmetallic materials [58] . Recently, BSA was used for in situ ligand exchange of hydrophobic QDs under a ultrasound condition [54] . The surface modification of ZCIS QDs with BSA might reduce the fluorescence quenching through increasing the distance between ZCIS QDs and FPP NPs. Therefore, FPPB, FPPBH6k NPs and FPPBH 31k NPs are highly fluorescent. Furthermore, BSA modification of ZCIS QDs could improve the biocompatability of ZCIS QDs.
The The magnetic property of FPPBH NPs was visually studied by placing FPPBH 31k NPs aqueous dispersion near a magnet. As shown in Figure S5 , FPPBH 31k NPs could rapidly move to the magnet within 30 min. This result indicated that FPPBH 31k NPs had a great potential for magnetic targeting. Moreover, the red fluorescent emitted from FPPBH 31k NPs provided additional evidence that BQDs NPs can be firmly conjugated onto the surface of FPP NPs.
The XPS analysis has been completed. The results were shown in Figure S6 and Table S1 . As expected for the in situ growing PB on Fe3O4 NPs, the N1s signal was detected at 398.88 eV. After PEI modification of FP NPs, the N1s signal was immensely strengthened. Due to the successful modification of BQDs on FPP NPs, new peaks at 1046.28 eV (Zn2p), 931.12 eV (Cu2p) and 443.50 eV (In3d) were detected. After modification with HA6k or HA 31k , the XPS spectra showed an increase in the C1s signal and decrease in the N1s signal, which provide a further evidence of successful HA modification. Furthermore, the C1s signal of FPPBH 31k NPs was stronger than that of FPPBH 6k NPs due to the higher molecular weight of HA 31k . The amount of BQDs on FPPB NPs has been quantified via XPS analysis. In Table S1 , the atomic percentage of zinc and iron of FPPB were 0.58% and 2.73%, respectively. Hence, the molar ratio of zinc to iron in FPPB NPs was calculated to be 0.212. According to Table S1, the molar ratio of carbon to iron was calculated to be 26.63, 31.17 and 35.77 in FPPB NPs, FPPBH6k NPs and FPPBH 31k NPs, respectively. The more amount of carbon on FPPBH 31k NPs was found due to the higher molecular weight of HA 31k than HA 6k .
To evaluated the colloidal stability, FPPBH 31k NPs were suspended in saline, plasma and RPMI-1640 medium. As shown in Figure S7 , the FPPBH 31k NPs could well dispersed in three kinds of physiologic medium and no aggregation or deposition was seen after stored at 4 °C for 7 days. The hydrodynamic diameter of the FPPBH 31k NPs in saline, plasma and RPMI-1640 medium had no significant change after one week storage (p>0.05) ( Table S2 ). The photo-stability study of FPPBH 31k NPs has investigated. As shown in Figure S8 , the fluorescence intensity of FPPBH 31k NPs at 700 nm in saline, plasma and RPMI-1640 medium had no apparent change after one week storage (p>0.05). All these results indicated that FPPBH 31k NPs possess good colloidal and photo stability.
Cellular uptake efficiency study
Cellular uptake of FPPB NPs, FPPBH 6k NPs and FPPBH 31k NPs was visualized by CLSM on HeLa cells (CD44 + ) and U87MG cells (CD44 -) [59] [60] . The iron concentration of these NPs was 10 mg/L. As shown in Figure 3, Flow cytometry analysis was used to quantitatively determine the cellular uptake of NPs. As shown in Figure S9 , the fluorescence intensities of HeLa cells treated with either FPPBH 6k NPs or FPPBH 31k NPs were significantly higher than U87MG cells. At the two groups of HeLa cells pretreated with free HA, the fluorescence intensity was as low as the control group. In addition, no strong fluorescence intensities were detected in U87MG cells with various treatment. Moreover, the fluorescence intensity of HeLa cells treated with FPPBH31k NPs was 1.5 fold higher than that treated with FPPBH 6k NPs, indicating that HA with higher MW had a better affinity to CD44 [52] . Therefore, FPPBH 31k NPs was selected for further experiments.
On the other hand, the cellular uptakes of FPPBH 6k NPs and FPPBH 31k NPs in HeLa cells and U87MG cells were all significantly enhanced by applying an external MF. The flow cytometry analysis provided additional evidence that the enhancement of cellular uptake of FPPBH 6k NPs and FPPBH 31k NPs in HeLa cells was attributed to the conjugation of HA ligands which can specifically target to CD44 receptor overexpressed on HeLa cells, and the interaction between the cells surface and NPs was strengthened by the external MF.
CD44 is a principal cell surface receptor, which over expressed in most cancer cells and normal cells. However, the HA-binding domain of CD44 exists in low-affinity state on normal cells and high-affinity state on tumor cells [61] [62] . In order to study tumor-specific targeting ability of FPPBH31k NPs, HUVEC cell line was selected as normal cell model. The cellular uptake of FPPBH 31k NPs on HUVEC cells and HeLa cells was visualized by CLSM. The fluorescence intensities of HUVEC cells and HeLa cells were also measured by flow cytometer. As shown in Figure S10 , HUVEC cells treated with FPPBH31k NPs, or FPPBH 31k NPs with external MF display no red fluorescence signal, which is similar to the control group. The fluorescence intensities of HeLa cells treated with either FPPBH 31k NPs or FPPBH 31k NPs with external MF were significantly stronger than HUVEC cells (p<0.01). These results indicated that FPPBH 31k NPs could specifically target to CD44 overexpressed tumor cells, instead of normal cells.
In vivo fluorescence imaging and biodistribution study
The tumor accumulation and biodistribution of FPPBH 31k NPs were evaluated using NIR fluorescence imaging to investigating the in vivo dual-targeting efficacy. FPPB NPs and FPPBH 31k NPs were intravenously (i.v.) injected into HeLa tumor-bearing BALB/c nude mice, respectively. A magnet was pasted on tumor site for 15 min before imaging. The variations of fluorescence intensity at tumor region were monitored within 48 h. As shown in Figure 4A and 4B, the fluorescence intensity gradually increased with increasing time, indicating the accumulation of NPs at tumor site. For the two groups without applying external MF, the fluorescence signal of the FPPBH31k NPs injected mice was stronger than that of FPPB NPs at 2h, 8h, 24h and 48h post-injection, respectively. The photon counts at region of interest (ROI) of FPPBH 31k NPs injected group was about 1.3 times higher than that of FPPB NPs at 48 h post-injection. The enhanced accumulation of FPPBH 31k NPs at tumor tissue could be attributed to the receptor-ligand interaction between HA and HeLa cells. By applying an external MF, the fluorescence intensity of FPPBH 31k NPs injected group MF was 1.1 times higher than that of without MF. This result demonstrated that FPPBH 31k NPs could actively accumulate at tumor site through ligand targeting, and the targeting effect was enhanced by the combination of an external MF.
To further evaluate the biodistribution of the injected NPs, major organs (liver, lung, spleen, kidney, heart and tumor) were collected at 48 h post-injection. As shown in Figure 4C and 4D, the strong fluorescence signal in liver and spleen suggested that the foreign NPs were taken up by reticuloendothelial system (RES) [63] . The fluorescence intensity of excised tumor injected by FPPBH31k NPs was 1.5 times higher than that of FPPB NPs, and increased 10% upon applying an external MF treatment ( Figure 4D ).
The biodistribution of NPs was further confirmed via ICP-OES by analyzing the iron concentration in major organs and tumor after ex vivo fluorescence images study. As shown in Figure S11 , after 48 h post-injection of NPs without and with MF, majority of iron was accumulated in liver, spleen and tumor by comparing with PBS injected HeLa tumor-bearing BALB/c nude mice. It was also found that the iron mass in each gram of tumor tissue was 20.8±2.2 μg (FPPB NPs), 27.2±1.9 μg (FPPBH31k NPs without MF) and 33.1±2.0 μg (FPPBH 31k NPs with MF). Therefore, we were able to calculate the uptaken percentages of NPs by tumor tissue to be 23.3±2.5% (FPPB NPs), 30.5±2.1% (FPPBH 31k NPs without MF) and 37.1±2.3% (FPPBH 31k NPs with MF), respectively.
In vitro and in vivo MR imaging study
To evaluate the magnetic properties of the NPs, the room temperature magnetization curves of Fe 3 O 4 NPs, FPPBH 6k NPs and FPPBH 31k NPs were obtained by a field-dependent magnetization measurement at 300 K (Figure 5A) The in vitro MR imaging capability of FPPBH 31k NPs was evaluated. The MR image became darker as the iron concentration of FPPBH 31k NPs increased ( Figure 5B ). The T 2 relaxation rate (1/T 2 ) increased with the iron concentration linearly in the range of iron concentration from 1.25 to 20 mg/L ( Figure 5C ). These results indicated that FPPBH 31k NPs exhibited the potential as a contrast agent for enhancing T 2 -weighted MR imaging.
The in vitro MR imaging of cells was evaluated too. As shown in Figure S12 , the results were similar to that of cellular uptake efficiency study. In HeLa cells treated with FPPBH 6k NPs and FPPBH 31k NPs groups, the T 2 -weighted MR signal intensities were significantly lower than U87MG cells. Moreover, the MR signal intensity of HeLa cells treated with FPPBH 31k NPs was lower than that treated with FPPBH 6k NPs, and the signal intensity of these two groups has become much lower after treated with external MF. These results indicated that FPPBH 31k NPs was better suited for targeted T 2 -weighted MR imaging of HeLa cells than FPPBH 6k NPs.
The in vivo MR imaging of FPPB NPs and FPPBH 31k NPs was then performed with the 3.0-T MR imaging system before and after intravenous injection at the time point of 8 h and 24 h (Figure 5D and 5E). The T 2 -weighted MR signals in the tumor region decreased gradually as the time increased. Moreover, the MR signal intensity of the FPPBH 31k NPs injected mice decreased more obviously than that of FPPB NPs at 8 h and 24 h, and further reduced upon applying an external MF. Therefore, both the fluorescence and MR imaging results proved that HA modification and the use of an external MF could enhance significantly the accumulation of FPPBH31k NPs in tumor. 
Photothermal effect of FPPBH 31k NPs
The photothermal effect of FPPBH 31k NPs was studied by monitoring the temperature of 3 mL RPMI-1640 medium containing FPPBH 31k NPs of various iron concentrations (20, 40 and To investigate the NIR photostability, FPPBH 31k NPs suspended in RPMI-1640 medium (iron concentration of 80 mg/L) was irradiated with 808 nm NIR laser for 10 min (LASER ON), followed by turning off the NIR laser and naturally cooling to the initial value at room temperature (LASER OFF). This cycle was repeated four times. As shown in Figure 6B , the temperature elevation of 22.9 °C was achieved after the first LASER ON, and no apparent decrease in the temperature elevation was observed at the second, the third and the fourth irradiation circle (p>0.05). Furthermore, only minor decrease of the absorbance at the NIR region was observed ( Figure 6C ), and no obvious change was observed in the fluorescence intensity ( Figure 6D ) after four irradiation cycles. It indicated the good photostability of FPPBH31k NPs after long period of NIR laser irradiation.
In vitro targeted photothermal ablation effect of FPPBH 31k NPs
To study the targeted photothermal ablation effect in vitro, HeLa cells incubated with FPPBH 31k NPs or FPPB NPs in 6-well plates were irradiated with an 808 nm NIR laser for 10 min with or without the use of the external MF at the bottom of the cell growing plate. Then, calcein AM was used to stain living HeLa cells to visualize the cell viability ( Figure  7A-H) . No apparent change in cell viability and density was observed when in presence of either the NPs or laser irradiation alone (Figure 7B-D) . However, a small amount of HeLa cell death was observed in the co-presence of FPPBH31k NPs and laser irradiation without MF ( Figure 7E ). It might be because the concentration of the FPPBH 31k was too low to achieve sufficient temperature elevation to induce cell death. Nevertheless, a significant cell death was observed in the laser irradiation region in the presence of FPPBH 31k NPs combining an external MF ( Figure 7F ). Compared with FPPBH 31k NPs combining NIR laser irradiation, FPPB NPs combining NIR laser irradiation induced less cell death no matter whether an external MF was used or not ( Figure 7G and 7H) .
The photo-thermal ablation effect of the FPPBH 31k NPs and FPPB NPs was further quantitatively evaluated by MTT assays. In Figure 7I , no obvious change in cell viability was seen at the iron concentration ranging from 0 to 40 mg/L without the use of NIR laser irradiation and external MF. However, FPPBH31k NPs combining external MF and laser showed significantly higher photothermal ablation effect than that no MF at various iron concentrations. Furthermore, the FPPB NPs treated HeLa cells showed slightly higher cell viability than FPPBH31k NPs upon NIR laser irradiation. All these results suggested that the the photothermal ablation effect of the NPs to HeLa cells could be greatly improved by the HA targeting and the use of an external MF, which can enhance cellular uptake of NPs.
In vivo PTT efficacy evaluation
The in vivo PTT was carried out on nude mice bearing HeLa cells with different treatments. When the volume of tumor reached approximately 100 mm 3 , the mice were randomly divided into seven groups: saline only, FPPB NPs only, FPPBH 31k NPs only, saline + laser, FPPB NPs + laser, FPPBH 31k NPs + laser and FPPBH 31k NPs + laser + MF (n=6 for each group). According to the results of NIR fluorescence and MR imaging, NIR irradiation was carried out at 24 h after i.v. injection of saline and NPs duet to the high NPs accumulation. The body temperature of each mouse was recorded using an infrared thermal camera. As shown in Figure 8A , no obvious elevation of temperature on tumor region was observed in saline + laser group after 10 min irradiation. In contrast, the average temperature on tumor region of mice in FPPB NPs + laser, FPPBH31k NPs + laser and FPPBH 31k NPs + laser + MF group was elevated to 40 °C, 46 °C and 49 °C, respectively. The higher temperature increment in FPPBH 31k NPs + laser + MF group was ascribed to the HA targeting ability of FPPBH 31k NPs to HeLa cells as well as magnetic targeting ability. The in vivo PTT efficacy was evaluated by measuring the tumor volume each 3 days after treatment ( Figure 8B and 8C) . In mice treated with saline only, FPPB NPs only, FPPBH 31k NPs only and saline + laser groups, the tumor volume increased from about 100 mm 3 to approximately 710 mm 3 over 18 days. For FPPB NPs + laser and FPPBH 31k NPs + laser group, on the 18th day after treatment, the size of tumor was increased to 383.2 ± 96.5 mm 3 and 271.6 ± 87.4 mm 3 , respectively. The tumor growth inhibition (TGI) was evaluated to be TGI: 46.18% and TGI: 61.85%. In marked contrast, the tumor volume was decreased to 71.6 ± 27.4 mm 3 for FPPBH 31k NPs + laser + MF group (TGI: 89.95%). Due to the CD44 receptor/magnetic dual targeting capability of FPPBH 31k NPs, the tumor growth was effectively inhibited. Therefore, FPPBH 31k NPs have a great potential to be used as a powerful agent for in vivo PTT of cancer.
Biocompatibility evaluation
HUVEC cells were incubated with FPPBH 31k NPs of different iron concentrations for 24, 48 and 72 h. Then, the viabilities of HUVEC cells were studied by MTT assays (Figure 9A) . The cell viabilities of HUVEC cells were more than 95% at the iron concentration as high as 8×10 3 mg/mL after incubation for 72 h. It indicated that FPPBH 31k NPs had good biocompatibility. We further evaluated the in vivo biocompatibility of FPPBH 31k NPs by body weight change and histopathologic examination. No significant body weight loss was observed, and the body weight increase rate of FPPBH 31k NPs injected group was similar to control ( Figure 9B ). Histological sections of vital organs excised at day 1 and day 30 demonstrated that neither apparent inflammation nor lesion in cellular structures was observed. These preliminary results indicated that FPPBH31k NPs could act as a secure theranostic agent for medical application. 
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